BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Drug Development

  Scott Hacker, MD Treats his Tenth Patient in Pivotal Phase 3 Clinical Trial of NOVOCART® 3D in Patients with Articular Cartilage Defects of the Knee

  Dr. Scott Hacker announced today that he has treated his tenth patient in the ongoing Phase 3 clinical trial of NOVOCART 3D, an investigational autologous chondrocyte transplantation system designed to treat articular cartilage defects of the knee.

  February 21, 2020

   · 

  4 min read
• BioCapital

  BIO Asia Conference in Tokyo Cancelled Amid COVID-19 Outbreak

  The Biotechnology Innovation Organization announced, it is canceling the annual BIO Asia conference in Tokyo scheduled for March 10-11.

  February 21, 2020

   · 

  2 min read
• Business

  Bench International Places Dr. Scott Gottlieb, Former FDA Commissioner, as a Director with Illumina

  Bench International, a leading global executive search firm, announces the opening of a new regional office located in the heart of San Diego’s life science community.

  February 21, 2020

   · 

  2 min read
• Genetown

  Jounce Therapeutics to Announce Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call on Thursday, February 27, 2020

  Jounce Therapeutics, Inc. announced that it will report fourth quarter and full year 2019 financial results and provide a corporate update before market open on Thursday, February 27, 2020.

  February 21, 2020

   · 

  1 min read
• Deals

  Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Feb. 21, 2020

  Atara Biotherapeutics, Inc. reported the grant of inducement awards to Kristin Yarema, its Chief Commercial Officer.

  February 21, 2020

   · 

  2 min read
• Biotech Bay

  89bio to Present at the SVB Leerink 9th Annual Global Healthcare Conference

  89bio, Inc. announced that Rohan Palekar, the company’s Chief Executive Officer, will present at the SVB Leerink 9th Annual Global Healthcare Conference on Wednesday, February 26, 2020 at 11:30 AM ET in New York, NY.

  February 21, 2020

   · 

  2 min read
• Biotech Bay

  Fist Assist Announces CE Mark and European Launch

  Fist Assist Devices, LLC, has received CE Mark and has begun marketing the Fist Assist device for vein enhancement and enlargement in the European Union and other CE Mark countries.

  February 21, 2020

   · 

  2 min read
• Deals

  Genprex, Inc. Announces Closing of $17,500,000 Common Stock Offering At-The-Market and Without Warrants

  Genprex, Inc., a clinical-stage gene therapy company utilizing a unique, non-viral proprietary platform designed to deliver tumor suppressor genes to cancer cells, announced that it closed its previously announced common stock offering priced at-the-market under Nasdaq rules.

  February 21, 2020

   · 

  6 min read
• Serinus Health Will Unveil Unique Suite of Patient Centric Services at HIMSS 2020

  Serinus Health is a leading provider of patient centric services for effective reduction of ER/Hospitalizations.

  February 21, 2020

   · 

  1 min read
• Biotech Bay

  BridgeBio Pharma And Eidos Therapeutics To Present At Upcoming Investor Conferences

  BridgeBio Pharma, Inc., together with affiliate company Eidos Therapeutics announced that they are presenting at two upcoming investor conferences

  February 21, 2020

   · 

  1 min read